https://www.polity.org.za
Deepening Democracy through Access to Information
Home / News / African News RSS ← Back
Africa|Health|Storage
Africa|Health|Storage
africa|health|storage
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

Gavi to buy 500 000 mpox vaccine doses from Bavarian Nordic

Close

Embed Video

Gavi to buy 500 000 mpox vaccine doses from Bavarian Nordic

Mpox test tubes
Photo by Reuters

18th September 2024

By: Reuters

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

The global vaccine group Gavi will buy 500 000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.

In 2024, there have been more than 25 000 suspected mpox cases and 723 deaths in Africa, mainly in the Democratic Republic of Congo, according to the World Health Organization, which has declared the outbreak a global health emergency.

Advertisement

Gavi, a public-private alliance which co-funds vaccine purchases for low-income countries, said it will spend up to $50-million on the plan, which includes the transportation, delivery and costs of administering the vaccines. The doses are due to be delivered this year.

Around 3.6-million doses of mpox vaccine have already been pledged to the DRC by rich nations which have stockpiles, the World Health Organization has said, but only a small portion has arrived so far. The WHO approved the vaccine for use on Friday last week.

Advertisement

Gavi's purchase, using a new facility set up after the Covid-19 pandemic to respond quickly to public health emergencies, could speed up the response in Congo and other affected countries.

The price of the vaccine was not disclosed. The $50-million investment would equate to around $100 per vaccine, lower than previous estimates. But the actual price is likely lower still because the money includes funding for the storage and roll-out.

Gavi chief executive Sania Nishtar said the priority was working with partners "to turn these vaccines into vaccinations as quickly and effectively as possible and, over time, to build a global vaccine stockpile."

The deal will significantly increase the availability of mpox vaccine for African countries, Bavarian Nordic chief executive Paul Chaplin said. Last week, the company said it would push back some existing orders to 2025, based on US government contracts, to focus on market needs now.

Mpox, which spreads through close contact and typically causes flu-like symptoms and pus-filled lesions, has been a public health problem in parts of Africa for decades. But vaccines have never previously been available outside clinical trials in affected countries in Africa, even after a different strain of the virus spread globally in 2022 and high-income countries used vaccines to help stem the outbreak.

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options

Email Registration Success

Thank you, you have successfully subscribed to one or more of Creamer Media’s email newsletters. You should start receiving the email newsletters in due course.

Our email newsletters may land in your junk or spam folder. To prevent this, kindly add newsletters@creamermedia.co.za to your address book or safe sender list. If you experience any issues with the receipt of our email newsletters, please email subscriptions@creamermedia.co.za